Jun 30, 2026 02:44AM
May 25, 2026 03:33AM
May 15, 2026 02:55AM
May 8, 2026 02:48AM
May 8, 2026 02:48AM
May 8, 2026 02:47AM
Mar 31, 2026 03:12AM Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program
Mar 23, 2026 03:50AM
Mar 17, 2026 07:39AM
Feb 6, 2026 06:17AM
Dec 8, 2025 06:42PM
Dec 8, 2025 04:52PM
Dec 8, 2025 04:40PM
Dec 4, 2025 02:13AM New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
Nov 18, 2025 07:02PM
Nov 13, 2025 06:50PM
Nov 10, 2025 02:16AM
Oct 26, 2025 10:56PM
Sep 2, 2025 11:01PM
Aug 25, 2025 03:26AM
Jul 30, 2025 10:54PM BioArtic: Latest data presented at AAIC 2025 reinforces lecanemab's clinical effect with consistent safety profile
May 15, 2025 04:56AM
May 8, 2025 07:49AM
Apr 1, 2025 06:14AM
Mar 25, 2025 03:08AM
Mar 17, 2025 01:49PM
Mar 3, 2025 03:17AM
Feb 28, 2025 08:11AM The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
Feb 18, 2025 02:13AM
Jan 31, 2025 07:12AM
Jan 26, 2025 09:50PM
Jan 13, 2025 09:49PM
Dec 4, 2024 09:44PM
Nov 27, 2024 09:47PM
Nov 14, 2024 12:00PM CHMP issues positive recommendation for approval of lecanemab in the EU
Oct 31, 2024 07:43PM
Aug 13, 2024 10:42PM
Aug 1, 2024 07:09AM
Jul 30, 2024 05:19PM
Jul 26, 2024 07:49AM
Jul 26, 2024 06:59AM
Jul 23, 2024 02:42AM Long-term treatment data for lecanemab to be presented at AAIC 2024
Jul 11, 2024 10:59PM
Jul 10, 2024 10:51PM
Jun 27, 2024 10:48PM
Jun 9, 2024 10:55PM
May 14, 2024 10:52PM
Mar 31, 2024 11:19PM
Mar 11, 2024 03:18AM BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress
Jan 11, 2024 01:16AM

324,761 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All